Given Imaging Ltd., a company focused in developing and marketing patient-friendly solutions for visualizing and detecting disorders of the GI tract, revealed that the U.S. Food and Drug ...
Conventional, catheter-based methods for monitoring esophageal and gastric pH can be uncomfortable, conspicuous, and limited in their ability to monitor pH for a long period of time. The Bravo ...
The U.S. Food and Drug Administration (FDA) is aware that Medtronic Plc (NYSE:MDT) and its subsidiary, Given Imaging Inc., have issued two letters to affected customers recommending that certain Bravo ...
Background and Aims: The tests that are currently available for the diagnosis of gastroesophageal reflux disease (GERD) lack the desired diagnostic accuracy. To date, only pH monitoring has been shown ...
Background and Aim: Nocturnal gastro-esophageal reflux causes heartburn and sleep disturbances impairing quality of life. Lifestyle modifications, like bed head elevation during sleep, are thought to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback